TY  - GEN
AU  - Idbaih,Ahmed
AU  - Dalmasso,Cyril
AU  - Kouwenhoven,Mathilde
AU  - Jeuken,Judith
AU  - Carpentier,Catherine
AU  - Gorlia,Thierry
AU  - Kros,Johan M
AU  - French,Pim
AU  - Teepen,Johannes
AU  - Broët,Philippe
AU  - Delattre,Olivier
AU  - Mokhtari,Karima
AU  - Sanson,Marc
AU  - Delattre,Jean-Yves
AU  - van den Bent,Martin
AU  - Hoang-Xuan,Khê
TI  - Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951
SN  - 1573-7373
PY  - 2011///0928
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Biomarkers, Tumor
KW  - analysis
KW  - Brain Neoplasms
KW  - drug therapy
KW  - Chromosome Aberrations
KW  - Chromosomes, Artificial, Bacterial
KW  - Combined Modality Therapy
KW  - Comparative Genomic Hybridization
KW  - Humans
KW  - In Situ Hybridization, Fluorescence
KW  - Kaplan-Meier Estimate
KW  - Lomustine
KW  - administration & dosage
KW  - Male
KW  - Middle Aged
KW  - Multicenter Studies as Topic
KW  - Oligodendroglioma
KW  - Procarbazine
KW  - Prognosis
KW  - Proportional Hazards Models
KW  - Radiotherapy
KW  - Retrospective Studies
KW  - Treatment Outcome
KW  - Vincristine
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s11060-010-0380-9
ER  -